Lung Cancer

In a recent study, researchers compared the safety, efficacy, and tolerability of 2 treatment combinations for patients with non-small cell lung cancer with brain metastases. To see results of the study,...

A recent study assessed the efficacy of atezolizumab across different lines of therapy in patients with advanced non-small cell lung cancer. For study results, including the objective response rate after 12...

The US Food and Drug Administration has approved the first treatment for a genetic mutation of non-small cell lung cancer, and also approved the diagnostic test for determining multiple genetic mutations...

The FDA has broadened the approval of a non-small cell lung cancer drug, previously approved in 2014.

The FDA approved the first anti-PD-1 therapy to be administered in combination with standard chemotherapy for the treatment of non-small cell lung cancer.

Researchers examined the potential risk of cardiac injury following radiation therapy in patients with stage III non-small-cell lung cancer.

The FDA has approved a new drug for the treatment of patients with metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer.

The FDA approved osimertinib for the treatment of patients with metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer.

Researchers studied bronchial and nasal epithelial gene expression to see if lung damage related to smoking was detectable via nasal tissue swab.

The research presented at the International Association for the Study of Lung Cancer examined the relationship between nonsteroidal anti-inflammatory drugs and the risk of lung cancer using the data from...